Abstract
ACE inhibition is emerging as a valuable adjunct to other drugs used after acute myocardial infarction (MI). This therapy has been validated in a number of major trials (see Table I), although questions remain regarding the optimal approach.
| Original language | English |
|---|---|
| Pages (from-to) | 59-63 |
| Number of pages | 5 |
| Journal | Current Therapeutics |
| Volume | 37 |
| Issue number | 10 |
| Publication status | Published or Issued - Oct 1996 |
| Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology